Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome

Journal of Experimental Medicine

Volumn 214, Issue 6, 2017, Pages 1737-1752

  Neudecker, Viola ^a,j   Haneklaus, Moritz ^b   Jensen, Owen ^j   Khailova, Ludmila ^j   Masterson, Joanne C ^c,j   Tye, Hazel ^d,e   Biette, Kathryn ^c,j   Jedlicka, Paul ^j   Brodsky, Kelley S ^j   Gerich, Mark E ^j   Mack, Matthias ^f   Robertson, Avril A B ^g   Cooper, Matthew A ^g   Furuta, Glenn T ^c,j   Dinarello, Charles A ^i,j   O'Neill, Luke A ^b   Eltzschig, Holger K ^h,j   Masters, Seth L ^d,e   McNamee, Eóin N ^j  

^a UNIVERSITY OF MUNICH   (Germany)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; MICRORNA 223; ANTIBODY; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; DEXTRAN SULFATE; MICRORNA; MIRN223 MICRORNA, HUMAN; MIRN223 MICRORNA, MOUSE; NANOPARTICLE; NLRP3 PROTEIN, HUMAN; NLRP3 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; ENZYME REPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; INTESTINE BIOPSY; IRRITABLE COLON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; COLITIS; DISEASE PREDISPOSITION; GENETICS; HEMATOPOIESIS; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; MONOCYTE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADULT; ANIMALS; ANTIBODIES; BASE SEQUENCE; COLITIS; DEXTRAN SULFATE; DISEASE SUSCEPTIBILITY; HEMATOPOIESIS; HUMANS; INFLAMMASOMES; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1BETA; INTESTINES; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MIDDLE AGED; MONOCYTES; MYELOID CELLS; NANOPARTICLES; NEUTROPHILS; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; RECEPTORS, CCR2;

EID: 85021853932     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20160462     Document Type: Article

References (49)

1. Allen, I.C., E.M. TeKippe, R.M. Woodford, J.M. Uronis, E.K. Holl, A.B. Rogers, H.H. Herfarth, C. Jobin, and J.P. Ting. 2010. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207:1045-1056. http ://dx .doi .org/10 .1084/jem .20100050
2. Andres, P.G., P.L. Beck, E. Mizoguchi, A. Mizoguchi, A.K. Bhan, T. Dawson, W.A. Kuziel, N. Maeda, R.P. MacDermott, D.K. Podolsky, and H.C. Reinecker. 2000. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164:6303-6312. http ://dx .doi .org/10 .4049/jimmunol .164 .12 .6303
3. Baek, D., J. Villén, C. Shin, F.D. Camargo, S.P. Gygi, and D.P. Bartel. 2008. The impact of microRNAs on protein output. Nature. 455:64-71. http ://dx .doi .org/10 .1038/nature07242
4. Bamias, G., D. Corridoni, T.T. Pizarro, and F. Cominelli. 2012. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine. 59:451-459. http ://dx .doi .org/10 .1016/j .cyto .2012 .06 .014
5. Bauer, C., P. Duewell, C. Mayer, H.A. Lehr, K.A. Fitzgerald, M. Dauer, J. Tschopp, S. Endres, E. Latz, and M. Schnurr. 2010. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 59:1192-1199. http ://dx .doi .org/10 .1136/gut .2009 .197822
6. Bauernfeind, F., A. Rieger, F.A. Schildberg, P.A. Knolle, J.L. Schmid-Burgk, and V. Hornung. 2012. NLRP3 inflammasome activity is negatively controlled by miR-223. J. Immunol. 189:4175-4181. http ://dx .doi .org/10 .4049/jimmunol .1201516
7. Bersudsky, M., L. Luski, D. Fishman, R.M. White, N. Ziv-Sokolovskaya, S. Dotan, P. Rider, I. Kaplanov, T. Aychek, C.A. Dinarello, et al. 2014. Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice. Gut. 63:598-609. http ://dx .doi .org/10 .1136/gutjnl-2012-303329
8. Brazil, J.C., N.A. Louis, and C.A. Parkos. 2013. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm. Bowel Dis. 19:1556-1565. http ://dx .doi .org/10 .1097/MIB .0b013e318281f54e
9. Calkins, C.M., D.D. Bensard, B.D. Shames, E.J. Pulido, E. Abraham, N. Fernandez, X. Meng, C.A. Dinarello, and R.C. McIntyre Jr. 2002. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. J. Endotoxin Res. 8:59-67
10. Casini-Raggi, V., L. Kam, Y.J. Chong, C. Fiocchi, T.T. Pizarro, and F. Cominelli. 1995. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J. Immunol. 154:2434-2440
11. Coll, R.C., A.A. Robertson, J.J. Chae, S.C. Higgins, R. Muñoz-Planillo, M.C. Inserra, I. Vetter, L.S. Dungan, B.G. Monks, A. Stutz, et al. 2015. A smallmolecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21:248-255. http ://dx .doi .org/10 .1038/nm .3806
12. Cominelli, F., C.C. Nast, R. Llerena, C.A. Dinarello, and R.D. Zipser. 1990. Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins. J. Clin. Invest. 85:582-586. http ://dx .doi .org/10 .1172/JCI114476
13. Dorhoi, A., M. Iannaccone, M. Farinacci, K.C. Faé, J. Schreiber, P. Moura-Alves, G. Nouailles, H.J. Mollenkopf, D. Oberbeck-Müller, S. Jörg, et al. 2013. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J. Clin. Invest. 123:4836-4848. http ://dx .doi .org/10 .1172/JCI67604
14. Elinav, E., T. Strowig, A.L. Kau, J. Henao-Mejia, C.A. Thaiss, C.J. Booth, D.R. Peaper, J. Bertin, S.C. Eisenbarth, J.I. Gordon, and R.A. Flavell. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 145:745-757. http ://dx .doi .org/10 .1016/j .cell .2011 .04 .022
15. Eulalio, A., L. Schulte, and J. Vogel. 2012. The mammalian microRNA response to bacterial infections. RNA Biol. 9:742-750. http ://dx .doi .org/10 .4161/rna .20018
16. Fiocchi, C. 1998. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology. 115:182-205. http ://dx .doi .org/10 .1016/S0016-5085 (98)70381-6
17. Gentner, B., G. Schira, A. Giustacchini, M. Amendola, B.D. Brown, M. Ponzoni, and L. Naldini. 2009. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods. 6:63-66. http ://dx .doi .org/10 .1038/nmeth .1277
18. Haneklaus, M., M. Gerlic, M. Kurowska-Stolarska, A.A. Rainey, D. Pich, I.B. McInnes, W. Hammerschmidt, L.A. O'Neill, and S.L. Masters. 2012. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J. Immunol. 189:3795-3799. http ://dx .doi .org/10 .4049/jimmunol .1200312
19. Haneklaus, M., M. Gerlic, L.A. O'Neill, and S.L. Masters. 2013. miR-223: Infection, inflammation and cancer. J. Intern. Med. 274:215-226. http ://dx .doi .org/10 .1111/joim .12099
20. Henao-Mejia, J., E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, C.A. Thaiss, A.L. Kau, S.C. Eisenbarth, M.J. Jurczak, et al. 2012. Inflammasomemediated dysbiosis regulates progression of NAF LD and obesity. Nature. 482:179-185. http ://dx .doi .org/10 .1038/nature10809
21. Hsu, S.H., B. Wang, J. Kota, J. Yu, S. Costinean, H. Kutay, L. Yu, S. Bai, K. La Perle, R.R. Chivukula, et al. 2012. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122:2871-2883. http ://dx .doi .org/10 .1172/JCI63539
22. Huang, H.Y., C.H. Chien, K.H. Jen, and H.D. Huang. 2006. RegRNA: An integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res. 34:W429-W434. http ://dx .doi .org/10 .1093/nar/gkl333
23. Janssen, H.L., H.W. Reesink, E.J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, K. Patel, A.J. van der Meer, A.K. Patick, A. Chen, Y. Zhou, et al. 2013. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368:1685-1694. http ://dx .doi .org/10 .1056/NEJMoa1209026
24. Johnnidis, J.B., M.H. Harris, R.T. Wheeler, S. Stehling-Sun, M.H. Lam, O. Kirak, T.R. Brummelkamp, M.D. Fleming, and F.D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 451:1125-1129. http ://dx .doi .org/10 .1038/nature06607
25. + efflux. J. Immunol. 194:1763-1775. http ://dx .doi .org/10 .4049/jimmunol .1401624
26. Li, T., M.J. Morgan, S. Choksi, Y. Zhang, Y.S. Kim, and Z.G. Liu. 2010. MicroRNAs modulate the noncanonical transcription factor NF-κB pathway by regulating expression of the kinase IKKα during macrophage differentiation. Nat. Immunol. 11:799-805. http ://dx .doi .org/10 .1038/ni .1918
27. Ligumsky, M., P.L. Simon, F. Karmeli, and D. Rachmilewitz. 1990. Role of interleukin 1 in inflammatory bowel disease: Enhanced production during active disease. Gut. 31:686-689. http ://dx .doi .org/10 .1136/gut .31 .6 .686
28. Lopetuso, L.R., S. Chowdhry, and T.T. Pizarro. 2013. Opposing functions of classic and novel IL-1 family members in gut health and disease. Front. Immunol. 4:181. http ://dx .doi .org/10 .3389/fimmu .2013 .00181
29. Mankan, A.K., T. Dau, D. Jenne, and V. Hornung. 2012. The NLRP3/ASC/caspase-1 axis regulates IL-1β processing in neutrophils. Eur. J. Immunol. 42:710-715. http ://dx .doi .org/10 .1002/eji .201141921
30. McNamee, E.N., J.D. Wermers, J.C. Masterson, C.B. Collins, M.D. Lebsack, S. Fillon, Z.D. Robinson, J. Grenawalt, J.J. Lee, P. Jedlicka, et al. 2010. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm. Bowel Dis. 16:743-752. http ://dx .doi .org/10 .1002/ibd .21148
31. McNamee, E.N., J.C. Masterson, P. Jedlicka, M. McManus, A. Grenz, C.B. Collins, M.F. Nold, C. Nold-Petry, P. Bufler, C.A. Dinarello, and J. Rivera-Nieves. 2011. Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Sci. USA. 108:16711-16716. http ://dx .doi .org/10 .1073/pnas .1111982108
32. Mosser, D.M., and X. Zhang. 2008. Activation of murine macrophages. Curr. Protoc. Immunol. Chapter 14:Unit 14.2. http ://dx .doi .org/10 .1002/0471142735 .im1402s83
33. Nagler-Anderson, C. 2001. Man the barrier! Strategic defences in the intestinal mucosa. Nat. Rev. Immunol. 1:59-67. http ://dx .doi .org/10 .1038/35095573
34. Nowarski, R., R. Jackson, N. Gagliani, M.R. de Zoete, N.W. Palm, W. Bailis, J.S. Low, C.C. Harman, M. Graham, E. Elinav, and R.A. Flavell. 2015. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell. 163:1444-1456. http ://dx .doi .org/10 .1016/j .cell .2015 .10 .072
35. O'Connell, R.M., D.S. Rao, A.A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10:111-122. http ://dx .doi .org/10 .1038/nri2708
36. Polytarchou, C., A. Oikonomopoulos, S. Mahurkar, A. Touroutoglou, G. Koukos, D.W. Hommes, and D. Iliopoulos. 2015. Assessment of circulating microRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology. Inflamm. Bowel Dis. 21:2533-2539. http ://dx .doi .org/10 .1097/MIB .0000000000000547
37. Pulikkan, J.A., V. Dengler, P.S. Peramangalam, A.A. Peer Zada, C. Müller-Tidow, S.K. Bohlander, D.G. Tenen, and G. Behre. 2010. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood. 115:1768-1778. http ://dx .doi .org/10 .1182/blood-2009-08-240101
38. Ramkissoon, S.H., L.A. Mainwaring, Y. Ogasawara, K. Keyvanfar, J.P. McCoy Jr., E.M. Sloand, S. Kajigaya, and N.S. Young. 2006. Hematopoieticspecific microRNA expression in human cells. Leuk. Res. 30:643-647. http ://dx .doi .org/10 .1016/j .leukres .2005 .09 .001
39. Reinecker, H.C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94:174-181. http ://dx .doi .org/10 .1111/j .1365-2249 .1993 .tb05997 .x
40. Satsangi, J., M.S. Silverberg, S. Vermeire, and J.F. Colombel. 2006. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut. 55:749-753. http ://dx .doi .org/10 .1136/gut .2005 .082909
41. Schaefer, J.S., D. Montufar-Solis, N. Vigneswaran, and J.R. Klein. 2011. Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/-mice precedes expression in the colon. J. Immunol. 187:5834-5841. http ://dx .doi .org/10 .4049/jimmunol .1100922
42. Seo, S.U., N. Kamada, R. Muñoz-Planillo, Y.G. Kim, D. Kim, Y. Koizumi, M. Hasegawa, S.D. Himpsl, H.P. Browne, T.D. Lawley, et al. 2015. Distinct commensals induce interleukin-1β via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity. 42:744-755. http ://dx .doi .org/10 .1016/j .immuni .2015 .03 .004
43. Shouval, D.S., A. Biswas, Y.H. Kang, A.E. Griffith, L. Konnikova, I.D. Mascanfroni, N.S. Redhu, S.M. Frei, M. Field, A.L. Doty, et al. 2016. Interleukin 1β mediates intestinal inflammation in mice and patients with interleukin 10 receptor deficiency. Gastroenterology. 151:1100-1104. http ://dx .doi .org/10 .1053/j .gastro .2016 .08 .055
44. Song-Zhao, G.X., N. Srinivasan, J. Pott, D. Baban, G. Frankel, and K.J. Maloy. 2014. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol. 7:763-774. http ://dx .doi .org/10 .1038/mi .2013 .94
45. Zaki, M.H., K.L. Boyd, P. Vogel, M.B. Kastan, M. Lamkanfi, and T.D. Kanneganti. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 32:379-391. http ://dx .doi .org/10 .1016/j .immuni .2010 .03 .003
46. Zaki, M.H., M. Lamkanfi, and T.D. Kanneganti. 2011. The Nlrp3 inflammasome: Contributions to intestinal homeostasis. Trends Immunol. 32:171-179. http ://dx .doi .org/10 .1016/j .it .2011 .02 .002
47. Zhang, J., S. Fu, S. Sun, Z. Li, and B. Guo. 2014. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol. 7:1139-1150. http ://dx .doi .org/10 .1038/mi .2014 .1
48. Zhou, H., J. Xiao, N. Wu, C. Liu, J. Xu, F. Liu, and L. Wu. 2015. MicroRNA-223 regulates the differentiation and function of intestinal dendritic cells and macrophages by targeting C/EBPβ. Cell Reports. 13:1149-1160. http ://dx .doi .org/10 .1016/j .celrep .2015 .09 .073
49. Zigmond, E., C. Varol, J. Farache, E. Elmaliah, A.T. Satpathy, G. Friedlander, M. Mack, N. Shpigel, I.G. Boneca, K.M. Murphy, et al. 2012. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 37:1076-1090. http ://dx .doi .org/10 .1016/j .immuni .2012 .08 .026